Cite
MLA Citation
Valentina Guarneri et al.. “Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.” Oncologist, vol. 20, 2015, pp. 1001–1010. http://access.bl.uk/ark:/81055/vdc_100151234080.0x00002f